Feedback / Questions
blarcamesine (Anavex 2-73 oral) - Anavex
blarcamesine IV (Anavex 2-73 IV) - Anavex
Anavex: CTAD 2016
(Anavex)
-
Dec 18, 2016 -
"Low-High dose was statistically significant to affect MMSE-Δ and ERP-Δ scores with MMSE-Δ (p=0.0285) and ERP-Δ (p=0.0168), respectively"
P2a data
•
Alzheimer's Disease
http://www.anavex.com/wp-content/uploads/CTAD-Anavex-December-2016-2.pdf
Dec 18, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious